Cardiovascular Risk Factors clinical trials

Explore recruiting cardiovascular risk factors clinical trials.

Recruiting cardiovascular risk factors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cardiovascular Risk Factors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Combined impact of cardiovascular polypill treatment and a specific nurse education program on adherence to therapy in patients with ACS: a randomized study

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Effect of metyrapone on cardiovascular risk factors in patients with adrenal incidentalomas and subclinical/mild Cushing's syndrome

Italy

Therapeutic use (Phase IV) EU CTIS Study details

The effect of transdermal 17-β-estradiol/progesterone supplementation on glucose regulation in peri- and postmenopausal women with type 1 and type 2 diabetes

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Effect and safety of liraglutide 3.0 mg on weight management in children with obesity aged 6 to <12 years: 56-week, double-blind, randomised, placebo-controlled trial

Portugal, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multimodal METformin and FINGER lifestyle intervention to prevent cognitive impairment and disability in older adults at risk for dementia: a phase IIb multi-national randomised, controlled trial.

Sweden, Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Long-term safety and efficacy of semaglutide s.c. once-weekly on weight management in children and adolescents (aged 6 to <18 years) with obesity or overweight

Belgium, Portugal, Sweden, Germany, Austria, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cardiovascular Risk Factors trials by city

Cardiovascular Risk Factors in Toronto Cardiovascular Risk Factors in Vancouver Cardiovascular Risk Factors in Montreal Cardiovascular Risk Factors in Calgary Cardiovascular Risk Factors in Edmonton Cardiovascular Risk Factors in Ottawa Cardiovascular Risk Factors in Winnipeg Cardiovascular Risk Factors in Quebec City Cardiovascular Risk Factors in Hamilton Cardiovascular Risk Factors in Kitchener Cardiovascular Risk Factors in London Cardiovascular Risk Factors in Halifax Cardiovascular Risk Factors in New York Cardiovascular Risk Factors in Los Angeles Cardiovascular Risk Factors in Chicago Cardiovascular Risk Factors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease